Closing Bell: Biosyent Inc up on Tuesday (RX)

In trading today, shares of Biosyent Inc opened at $10.13 and closed at $10.15. prices ranged from $10.08 to $10.15.

The price boosted 0.20 percent from the previous day's close of $10.13.

Today across North America, the TSX Composite closed 0.34% at 22751.68, the S&P 500 closed 0.28% at 5631.22, the Dow Jones Industrial Average closed 0.53% at 40211.72 and the Nasdaq Composite closed 0.40% at 18472.57.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 5,253 on 11 total trades. On average, Biosyent Inc has traded 2,580 shares over the last 5-days and 6,833 year-to-date.

The TSX-V overall saw 4,226 price advancers against 1,023 declines and 82 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $10.75 (June 21,2024) and low as $7.41 (July 21,2023). Moreover, in the last 12 months, Biosyent Inc's shares have soared 33.55%, while this year, they have raised 10.09%.

It announced a 0.04 dividend on May 16/24, with an May 31/24 ex-date and June 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $117.35 million on a float of 11,584 shares outstanding. Its annual EPS is $0.58.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc has an average recommendation of "Moderate Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..